1. Biotech IPO bonanza: Legend Biotech, Forma Therapeutics, Repare — COVID-19 could slow progress in reducing cancer death, NCI warns — ASCO 2020 news from Merck, AstraZeneca, Pfizer, more — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Stemless reverse

Discussion in 'Tornier' started by anonymous, May 20, 2016 at 8:06 PM.

  1. anonymous

    anonymous Guest

    For you guys out there who are with designing docs, how long till this hits the pavement?
     
  2. anonymous

    anonymous Guest

    FX Shoulder has an IDE going on right now. Their parent company, FX Solutions, has been implanting stemless reverses for almost five years in Europe. Hopefully, the FDA will recognize their base is solid and the system works well in order to get the ball rolling for the rest of the industry.